Lewis J. Stuart
Director/Board Member bij Linkage Biosciences, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Zachary C. Antovich | M | - |
Linkage Biosciences, Inc.
 Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | 20 jaar |
| Jeff M. Krauss | M | 67 |
Linkage Biosciences, Inc.
Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | - |
| Pete Henig | M | - |
Linkage Biosciences, Inc.
Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | - |
| Rebecca Bishop | F | 58 |
Linkage Biosciences, Inc.
Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | 15 jaar |
| Carl Grumet | M | - |
Linkage Biosciences, Inc.
Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | - |
| Clifford Lowell | M | - |
Linkage Biosciences, Inc.
Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | - |
| Kai Quinto | M | - |
Linkage Biosciences, Inc.
Linkage Biosciences, Inc. Medical SpecialtiesHealth Technology Linkage Biosciences, Inc. engages in the development and marketing of molecular diagnostic products. It offers ABO, HLA, HPA and KIR typing kits, accessories, and instrumentation products. The company was founded by Zachary Antovich in March 2004 and is headquartered in San Francisco, CA. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Louis Lange | M | 72 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 19 jaar |
| Dean Schorno | M | 61 | 13 jaar | |
| Paul MacLeman | M | 58 | 3 jaar | |
| Randal Scott | M | 66 | 12 jaar | |
| John D. Bluth | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Henry Fuchs | M | 66 | 6 jaar | |
| Kenneth Lee | M | 76 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 7 jaar |
| Tricia Borga Suvari | F | 63 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 11 jaar |
| Kathy Hibbs | F | 60 | 5 jaar | |
| Huw David Jones | M | 61 | 4 jaar | |
| Joffre B. Baker | M | 76 | 12 jaar | |
| Christopher Chai | M | 58 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 8 jaar |
| Felix Baker | M | 55 | 7 jaar | |
| Woodrow Myers | M | 70 | 7 jaar | |
| Jason W. Radford | M | 42 | 4 jaar | |
| Amy P. Sing | M | 65 | - | |
| Geoffrey Parker | M | 59 | 3 jaar | |
| Frederic Pla | M | 65 | 6 jaar | |
| Sidney Charles Hack | M | 86 | 3 jaar | |
| Mervyn Cass | M | 83 | 3 jaar | |
| Eric Lefebvre | M | 60 | 2 jaar | |
| Adrienne MacMillan | F | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Randall Livingston | M | 70 | 12 jaar | |
| Harish Shantharam | M | 44 | 1 jaar | |
| Carol Karp | F | 71 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Paul J. Frohna | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 2 jaar |
| Samuel D. Colella | M | 84 | 13 jaar | |
| Colin Hislop | M | 66 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 jaar |
| Markus Jerling | M | 72 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 4 jaar |
| Huang I-Zu | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 6 jaar |
| Shay Weisbrich | F | 71 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 1 jaar |
| Angela Parker | F | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Santo Costa | M | 78 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 8 jaar |
| R. Scott Greer | M | 65 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 jaar |
| David J. Sparling | M | 52 | - | |
| Patricia E. Dumond | F | 59 | 10 jaar | |
| M. Luisa Ashdown | F | - | 1 jaar | |
| Kenneth F. Boehm | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 4 jaar |
| Rebecca Lucia | F | 52 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 1 jaar |
| Whedy Wang | M | 60 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 9 jaar |
| Costa G. Sevastopoulos | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Maureen T. Cronin | M | 70 | 9 jaar | |
| Ivan Jasenko | M | 58 | 3 jaar | |
| Peter M. Strumph | M | 59 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 10 jaar |
| Louis Yu | M | 73 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 1 jaar |
| Andrew Wolff | M | 69 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 10 jaar |
| Karin Walker | F | 60 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 jaar |
| Samuel Levy | M | - | - | |
| Benjamin Silluzio | M | 48 | 1 jaar | |
| Phillip Febbo | M | 57 | 5 jaar | |
| Danielle Savaglio | F | - | - | |
| Laura Beggrow | F | - | 9 jaar | |
| Henry Liu | M | 50 | 2 jaar | |
| Yan Bin Liu | M | 44 | 1 jaar | |
| Jacquie Cooke Haggarty | F | 45 | - | |
| Cam Gallagher | M | 54 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 12 jaar |
| Dennis D. Kim | M | 54 | 2 jaar | |
| Joseph M. Davie | M | 84 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 jaar |
| Jessica Owens | F | - | 1 jaar | |
| Brent Blackburn | M | 63 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 7 jaar |
| Thomas Shenk | M | 77 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 5 jaar |
| Ginger Graham | F | 68 | 9 jaar | |
| John Groom George | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Peter Hutt | M | 89 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 8 jaar |
| Brook Byers | M | 78 | 10 jaar | |
| Peter G. Milner | M | 68 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 17 jaar |
| Michael Vedda | M | 58 | - | |
| Huw Jones | M | 62 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Andrea Huch | F | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| David C. McCaleb | M | 70 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 10 jaar |
| Thomas L. Gutshall | M | 85 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 15 jaar |
| Mel Bridges | M | 73 | 1 jaar | |
| Kim McEachron | F | 68 | 7 jaar | |
| Hsiao Lieu | M | 53 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 jaar |
| Anne Champsaur | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 3 jaar |
| Dan Spiegelman | M | 65 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 11 jaar |
| Richard M. Lawn | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 14 jaar |
| Barbara McNeil | M | 83 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 14 jaar |
| Jennifer Hodge | F | 55 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 7 jaar |
| Bruce Philip Pritchard | M | 51 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 2 jaar |
| Michael T. Sweeney | M | 63 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 4 jaar |
| Philip Wells | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 1 jaar |
| Greg Brown | M | 61 | - | |
| David Banks | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 4 jaar |
| Luiz Belardinelli | M | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | - |
| Diane L. Liguori | F | - |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 16 jaar |
| Lorenz Muller | M | 60 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 10 jaar |
| Anders Waas | M | 67 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 7 jaar |
| Douglas T. Sheehy | M | 57 |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | 5 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 85 | 88.54% |
| Australië | 11 | 11.46% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Lewis J. Stuart
- Persoonlijk netwerk
